Bullish option flow detected in Bristol Myers (BMY) Squibb with 19,247 calls trading, 3x expected, and implied vol increasing almost 2 points to 30.67%. Aug-25 45 calls and Sep-25 44 puts are the most active options, with total volume in those strikes near 14,600 contracts. The Put/Call Ratio is 0.32. Earnings are expected on October 30th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers price target lowered to $46 from $52 at UBS
- Options Volatility and Implied Earnings Moves Today, August 01, 2025
- Bristol Myers price target lowered to $47 from $51 at Citi
- Sell Rating for Bristol-Myers Squibb Due to Overly Optimistic Estimates and Clinical Trial Delays
- Cautious Hold Rating on Bristol-Myers Squibb Amid Strong Q2 Results and Future Challenges